Type 1 diabetes

Psychometric validation of the hyperglycaemia avoidance scale UK (HAS‐UK)

Diabet MedPublished Psychometric validation study

Authors' conclusion

The HAS-UK is a reliable measure with acceptable structural validity and is likely to be useful for evaluating hyperglycaemia aversion in people with type 1 diabetes. Future research would benefit from investigating further psychometric properties including test-retest reliability, sensitivity to change, and clinical significance of scores.

Study context

Population
Adults with T1D in three separate research studies; mean age 49.5 years, 58.0% women, mean diabetes duration 29 years; 192 (44.5%) on MDI, 229 (53.1%) on insulin pump5 excluded, incomplete responses
Participants
431 adults
Outcome
Psychometric properties of the HAS-UK: factor structure, internal consistency and convergent validity
Methodological detailsexploratory factor analysis, data from three research studies
  • Exploratory factor analysis
  • Data from three research studies

Performance

As reported in the abstract

Psychometric properties of the HAS-UK
  • Exploratory factor analysis revealed a 3-factor solution
  • Acceptable internal consistency for 'worry' and 'blood glucose decisions' factors

Further findings

Convergent validity: HAS-UK scores by treatment and monitoring

HAS-UK total score higher with insulin pumps vs MDI
'Blood glucose decisions' score higher with continuous blood glucose sensor vs meter

Original publication

Psychometric validation of the hyperglycaemia avoidance scale UK (HAS‐UK). Diabet Med. Published 30 April 2024. doi:10.1111/dme.15342

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.